首页> 外文期刊>薬物動態 >Characterization of drug transport mechanism across the placental barrier using cultured trophoblast
【24h】

Characterization of drug transport mechanism across the placental barrier using cultured trophoblast

机译:使用培养滋养细胞对胎盘屏障的药物传输机制的表征

获取原文
获取原文并翻译 | 示例
           

摘要

Drug transport mechanism across the placenta is still unknown.The trophoblast that from the placental barrier have an important role in controlling the passage of molecules from mother to fetus.In this study,we investigated that dipeptide and folic acid are actively transported by transporters on the trophoblast.The human choriocarcinoma cell line.BeWo,was cultured on tissue culture plates.When the cells reached confluence,durg uptake experiments were performed.The uptake of [~(14)C]glycylsarcosine ([~(14)C]Gly-Sar)by BeWo cells was saturated at higher concentration.The metabolic inhibitors singnificantly inhibited the uptake of [~(14)C]Gly-Sar.In addition,various di- or tri- peptides inhibited the uptake of [~(14)C]Gly-Sar.The uptake of [~3H]folic acid was saturable at higher concentrations and inhibited by metabolic ilhibitors.Analogs of folic acid,methotrexate and 5-methyltetrahydrofolate,inhibited the uptake of [~3H]folic acid by BeWo cells.Kinetic analysis using Lineweaver-Burk plots revealed that methotrezate competitively inhibited the uptake of [~3H]folic acid and folic acid competitively inhibited the uptake of [~3H]methotrexate.The findings confirm that dipeptide and folic acid are transported by their transporters on BeWo cell monolayers.The dehydroepiandrosteron sulfate (DHEAS)uptake by BeWo cells from basal side of the cells was higher than that from apical side,and the uptake was inhibited by am excess amount of DHEAS.The findings confirm that the carrier of DHEAS exists on the basal membrane of BeWo cells.This work demonstrated the possibility of using a human monolayer-forming cell line.BeWo,to characterize putative trans-trophoblast transport mechanisms and their potential roles in controlling nutrients and drug across the placental barrier.
机译:胎盘的药物运输机制仍然未知。来自胎盘屏障的滋养管具有在控制来自母体到胎儿的分子的通过方面具有重要作用。在本研究中,我们研究了二肽和叶酸被转运蛋白积极运输脱蛋细胞。人绒毛膜细胞系列。在组织培养板上培养。当细胞达到汇合时,进行了Durg摄取实验。[〜(14)c]甘氨酸([〜(14)c] gly - 通过Bewo细胞以更高的浓度饱和。代谢抑制剂整齐地抑制[〜(14)c] gly-sar.in添加,各种二肽或三肽抑制[〜(14)c的吸收]甘道-SAR。[〜3H]叶酸的摄取以较高的浓度可饱和,并通过代谢inlhibitors抑制。叶酸,甲氨蝶呤和5-甲基四氢醇的胰岛,抑制Bewo细胞吸收[〜3H]叶酸。使用LINEWEAVER-BURK PL的动力学分析OTS显示,甲醇酸甲酸盐竞争抑制[〜3H]叶酸的摄取和叶酸竞争性地抑制[〜3H]甲氨蝶呤的摄取。结果证实,二肽和叶酸被其转运蛋白在Bewo细胞单层上运输。脱氢硫酸酯(DHEAS)来自细胞基底侧的Bewo细胞的摄取量高于顶端侧的细胞,并且通过过量的DHEAS抑制摄取。结果证实DHEAS的载体存在于Bewo细胞的基础膜上。这项工作证明了使用人单层形成细胞系的可能性.Bewo,以表征推定的反递质传输机制及其在胎盘屏障中控制营养和药物的潜在作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号